Evolus, Inc. (NasdaqGM: EOLS)
Health Care · Pharmaceuticals · US
$7.80
+0.78% today · +23.6% 1Y
Evolus, Inc. (NasdaqGM: EOLS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $511.23M and employs 353 people.
Over the last twelve months the share price has gained 23.6%, trading between 3.86 and 9.31.
Tweenvest scores Evolus, Inc. across four factors: quality 41/100, value 69/100, growth 100/100. Its strongest factor is growth.
EOLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $511.23M
- Revenue (TTM)
- $316.49M
- P/E
- —
- EPS
- -0.53
- Dividend yield
- —
- Beta (5Y)
- 1.34
- 52-week high
- $9.31
- 52-week low
- $3.86
- Avg volume (3M)
- —
- Shares outstanding
- 66.05M
- Employees
- 353
- Next earnings
- —
About Evolus, Inc.
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
- ISIN
- US30052C1071
- Founded
- 2012
- Listed since
- Feb 8, 2018
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orchid Pharma LimitedNSEI: ORCHPHARMA | $521.52M | Rs990.00 | -7.03% |
| Shanghai Shen Lian Biomedical CorporationSHSE: 688098 | $517.91M | CN¥8.46 | +1.08% |
| Gujarat Themis Biosyn LimitedBSE: 506879 | $516.86M | Rs382.35 | -8.38% |
| Beximco Pharmaceuticals PLC.DSE: BXPHARMA | $516.32M | Tk142.60 | +2.15% |
| Shaanxi Kanghui Pharmaceutical Co., Ltd.SHSE: 603139 | $508.94M | CN¥34.18 | -5.84% |
| Tilray Brands, Inc.NasdaqGS: TLRY | $508.92M | $3.59 | -3.36% |
| Guangdong Lifestrong Pharmacy Co., Ltd.SZSE: 301111 | $508.07M | CN¥21.30 | -4.83% |
| Novartis India LimitedBSE: 500672 | $504.65M | Rs1,967.85 | +0.33% |
Figures last refreshed Oct 4, 2026.